APA

Meguro Y., Miyano K., Hirayama S., Yoshida Y., Ishibashi N., Ogino T., Fujii Y., Manabe S., Eto M., Nonaka M., Fujii H., Ueta Y., Narita M., Sata N., Yada T. & Uezono Y. (20180905). Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. : Journal of pharmacological sciences.

Chicago

Meguro Yoshiyuki, Miyano Kanako, Hirayama Shigeto, Yoshida Yuki, Ishibashi Naoto, Ogino Takumi, Fujii Yuriko, Manabe Sei, Eto Moeko, Nonaka Miki, Fujii Hideaki, Ueta Yoichi, Narita Minoru, Sata Naohiro, Yada Toshihiko and Uezono Yasuhito. 20180905. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. : Journal of pharmacological sciences.

Harvard

Meguro Y., Miyano K., Hirayama S., Yoshida Y., Ishibashi N., Ogino T., Fujii Y., Manabe S., Eto M., Nonaka M., Fujii H., Ueta Y., Narita M., Sata N., Yada T. and Uezono Y. (20180905). Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. : Journal of pharmacological sciences.

MLA

Meguro Yoshiyuki, Miyano Kanako, Hirayama Shigeto, Yoshida Yuki, Ishibashi Naoto, Ogino Takumi, Fujii Yuriko, Manabe Sei, Eto Moeko, Nonaka Miki, Fujii Hideaki, Ueta Yoichi, Narita Minoru, Sata Naohiro, Yada Toshihiko and Uezono Yasuhito. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator. : Journal of pharmacological sciences. 20180905.